Overall, many had meaningful weight loss, but some individual results varied, according to the Cleveland Clinic: "Those treated for obesity lost an average of 8.4% of body weight before discontinuation and regained an average of 0.5% one year later Those treated for type 2 diabetes lost an average of 4.4% of body weight before discontinuation and lost an additional 1.3% of body weight one year later In the obesity group, 55% gained weight in the year after discontinuation, while 45% kept losing or stayed the same In the diabetes group, 44% gained weight, while 56% kept losing or stayed the same" There were two primary issues that led to patients stopping the medication, which were cost or insurance coverage, and side effects
The manufacturers' patient information leaflets (PILs) and Summaries of Product Characteristics (SmPCs) provide clear guidance on approved injection sites to optimise treatment outcomes and patient safety
As a result, meals tend to feel complete with smaller portions
Food hangs out in your stomach longer, which means you feel full, but also that big, heavy, or high-fat meals, and yes, cocktails, are more likely to result in nausea, reflux, or bloat
Effectiveness One study followed 2,000 participants for 68 weeks
The Study Researchers at the Fralin Biomedical Research Institute at Virginia Tech Carilion have investigated in two studies the relationship between the use of GLP-1 (Glucagon-like peptide-1) agonists and the self-reported patterns of drinking and alcohol craving with participants with a BMI over 30
